CCM
ORMP icon

Covington Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Covington Capital Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Hold
325
– – ﹤0.01% 1069
2022
Q2 		$1K Hold
325
– – ﹤0.01% 1042
2022
Q1 		$3K Hold
325
– – ﹤0.01% 1011
2021
Q4 		$5K Hold
325
– – ﹤0.01% 874
2021
Q3 		$7K Buy
+325
New +$5.54K ﹤0.01% 854

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Covington Capital Management's ORMP Position: Q3 2022 in Review

Covington Capital Management held its Oramed Pharmaceuticals (ORMP) position steady in Q3 2022 at 325 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Covington Capital Management first reported a position in ORMP in Q3 2021 and has held it in 5 quarters since. The position peaked at $7K in Q3 2021. 71 funds tracked by Wall St. Rank hold ORMP as of Q3 2022.

  • Covington Capital Management held 325 shares of Oramed Pharmaceuticals worth $2K as of Q3 2022.
  • Covington Capital Management left its Oramed Pharmaceuticals share count unchanged in Q3 2022.
  • Oramed Pharmaceuticals made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #1069 holding.
  • Covington Capital Management first reported a position in Oramed Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
  • Covington Capital Management's Oramed Pharmaceuticals position peaked at $7K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.